Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Aug;38(8):1862–1863. doi: 10.1128/aac.38.8.1862

Efficacy of azithromycin as a causal prophylactic agent against murine malaria.

S L Andersen 1, A L Ager 1, P McGreevy 1, B G Schuster 1, W Ellis 1, J Berman 1
PMCID: PMC284651  PMID: 7986022

Abstract

The efficacy of the newly marketed azalide azithromycin was compared with that of the clinical agent doxycycline in a murine model of sporozoite-induced malaria. Drug was administered once; Plasmodium yoelii sporozoites were administered 2 h later; survival at day 60 was determined. For parenterally administered drug, 160 mg of azithromycin or doxycycline per kg of body weight was 100% effective; 40 mg of azithromycin per kg was 80% effective, but 40 mg of doxycycline per kg was 40% effective. Orally administered azithromycin was somewhat less effective than parenterally administered drug, consistent with the 37% clinical oral bioavailability of this agent. For orally administered azithromycin, 160 mg/kg was 100% effective and 40 mg/kg was 40% effective. The efficacy of azithromycin in comparison with that of doxycycline and the known prolonged levels of azithromycin in the livers of humans suggest that azithromycin has potential as a clinical causal prophylactic agent for malaria.

Full text

PDF
1862

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basco L. K., Ramiliarisoa O., Le Bras J. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg. 1994 Feb;50(2):193–199. doi: 10.4269/ajtmh.1994.50.193. [DOI] [PubMed] [Google Scholar]
  2. Davidson D. E., Jr, Ager A. L., Brown J. L., Chapple F. E., Whitmire R. E., Rossan R. N. New tissue schizontocidal antimalarial drugs. Bull World Health Organ. 1981;59(3):463–479. [PMC free article] [PubMed] [Google Scholar]
  3. Kuschner R. A., Heppner D. G., Andersen S. L., Wellde B. T., Hall T., Schneider I., Ballou W. R., Foulds G., Sadoff J. C., Schuster B. Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum. Lancet. 1994 Jun 4;343(8910):1396–1397. doi: 10.1016/s0140-6736(94)92526-7. [DOI] [PubMed] [Google Scholar]
  4. Schlesinger P. H., Krogstad D. J., Herwaldt B. L. Antimalarial agents: mechanisms of action. Antimicrob Agents Chemother. 1988 Jun;32(6):793–798. doi: 10.1128/aac.32.6.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Shmuklarsky M. J., Boudreau E. F., Pang L. W., Smith J. I., Schneider I., Fleckenstein L., Abdelrahim M. M., Canfield C. J., Schuster B. Failure of doxycycline as a causal prophylactic agent against Plasmodium falciparum malaria in healthy nonimmune volunteers. Ann Intern Med. 1994 Feb 15;120(4):294–299. doi: 10.7326/0003-4819-120-4-199402150-00006. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES